Security key
64136E102
Neuphoria Therapeutics Inc. - Common Stock, $0.00001 par value per share (NEUP)
CUSIP: 64136E102
Q2 2026 13F Holders as of 30 Jun 2026
- Security type / class
- Equity / Common Stock, $0.00001 par value per share
- Total 13F shares
- 26,500
- Total 13F value
- $115,000
- Share change
- 0
- SEC-reported price per share
- $4.34
- Number of holders
- 1
- Shares outstanding
- 5,420,049
Holder snapshot
3 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2026
Institutions
1
Top holders
1
NEUP full security history
Ownership snapshot
Full 13F holder table
Previous quarter: Q1 2026
Neuphoria Therapeutics Inc. SEC filings
Neuphoria Therapeutics Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 64136E102
Recent filing periods:
Ownership snapshot
Top reported holders of NEUP - Neuphoria Therapeutics Inc. - Common Stock, $0.00001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Lynx1 Capital Management LP
Disclosed value leader
Lynx1 Capital Management LP
Comparable rows
15/15
Latest evidence
31 Mar 2026
3/4/5
13D/G
13F
Lead comparable stake: 16%
13D/G row: Lynx1 Capital Management LP
Showing 1-6 of 15 holder rows.
Quick read
Lynx1 Capital Management LP leads the comparable SEC ownership view at 16%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Lynx1 Capital Management LP's linked filing trail.
Comparable ownership
Top 5
Lynx1 Capital Management LP
16%
Shay Capital LLC
7.3%
Coastlands Capital LP
5.1%
ARMISTICE CAPITAL, LLC
5%
Apeiron Investment Group Ltd.
4.5%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Lynx1 Capital Management LP |
3/4/5
13D/G
13F
10%+ Owner · Company
|
16%
from 13D/G
|
$10,381,390
875,328 shares
|
— | 21 Oct 2025 |
| Shay Capital LLC |
13D/G
13F
Company
|
7.3%
|
$2,035,520
171,629 shares
|
$0 | 24 Oct 2025 |
| Coastlands Capital LP |
13D/G
|
5.1%
|
$1,423,200
120,000 shares
|
$0 | 05 Nov 2025 |
| ARMISTICE CAPITAL, LLC |
13D/G
|
5%
|
$5,365,401
1,033,796 shares
|
$0 | 31 Dec 2024 |
| Apeiron Investment Group Ltd. |
13D/G
|
4.5%
|
$376,887
72,618 shares
|
$0 | 24 Jan 2025 |
| Baselake Partners, LP |
13D/G
|
4.1%
|
$862,110
222,222 shares
|
$0 | 31 Dec 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
1
Shares
26,500
Rows available
1
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2026 vs Q1 2026 Across Filers
Q1 2026 holders
19
Q2 2026 holders
1
Holder diff
-18
| Investor | Q1 2026 Shares | Q2 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q2 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend